These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1074 related articles for article (PubMed ID: 3263552)

  • 1. Whole body hyperthermia (41-42 degrees C) induces interleukin-1 in vivo.
    Neville AJ; Sauder DN
    Lymphokine Res; 1988; 7(3):201-6. PubMed ID: 3263552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of fever-range whole-body hyperthermia on the LPS-induced acute inflammatory response.
    Ostberg JR; Taylor SL; Baumann H; Repasky EA
    J Leukoc Biol; 2000 Dec; 68(6):815-20. PubMed ID: 11129648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of whole body hyperthermia on the immune cell activity of cancer patients.
    Park MM; Hornback NB; Endres S; Dinarello CA
    Lymphokine Res; 1990; 9(2):213-23. PubMed ID: 2110991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematological effects of radiant heat-induced whole body hyperthermia on dogs.
    Woods JP; Schmitt-Tiggelaar CL; d'Oleire F; Rosenthal RC; Robins HI
    Can J Vet Res; 1996 Jan; 60(1):75-8. PubMed ID: 8826000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing heat shock factor 1 by small interfering RNA abrogates heat shock-induced cardioprotection against ischemia-reperfusion injury in mice.
    Yin C; Xi L; Wang X; Eapen M; Kukreja RC
    J Mol Cell Cardiol; 2005 Oct; 39(4):681-9. PubMed ID: 16125197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
    Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
    Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of radiant whole-body hyperthermia at temperatures >41.5 degrees C and practical guidelines for the treatment of adults. The German 'Interdisciplinary Working Group on Hyperthermia'.
    Hildebrandt B; Hegewisch-Becker S; Kerner T; Nierhaus A; Bakhshandeh-Bath A; Janni W; Zumschlinge R; Sommer H; Riess H; Wust P;
    Int J Hyperthermia; 2005 Mar; 21(2):169-83. PubMed ID: 15764358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats.
    Sakaguchi Y; Stephens LC; Makino M; Kaneko T; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
    Cancer Res; 1995 Nov; 55(22):5459-64. PubMed ID: 7585616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by whole-body hyperthermia with far-infrared rays of the growth of spontaneous mammary tumours in mice.
    Udagawa Y; Nagasawa H; Kiyokawa S
    Anticancer Res; 1999; 19(5B):4125-30. PubMed ID: 10628363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice.
    Kokura S; Adachi S; Manabe E; Mizushima K; Hattori T; Okuda T; Nakabe N; Handa O; Takagi T; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 May; 23(3):259-65. PubMed ID: 17523018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nontoxic system for 41.8 degrees C whole-body hyperthermia: results of a Phase I study using a radiant heat device.
    Robins HI; Dennis WH; Neville AJ; Shecterle LM; Martin PA; Grossman J; Davis TE; Neville SR; Gillis WK; Rusy BF
    Cancer Res; 1985 Aug; 45(8):3937-44. PubMed ID: 4016761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.
    Hegewisch-Becker S; Braun K; Otte M; Corovic A; Atanackovic D; Nierhaus A; Hossfeld DK; Pantel K
    Clin Cancer Res; 2003 Jun; 9(6):2079-84. PubMed ID: 12796371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
    Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
    Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine production after whole body and localized hyperthermia.
    Haveman J; Geerdink AG; Rodermond HM
    Int J Hyperthermia; 1996; 12(6):791-800. PubMed ID: 8950159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia induces IL-1 alpha but does not decrease release of IL-1 alpha or TNF-alpha after endotoxin.
    Blake D; Bessey P; Karl I; Nunnally I; Hotchkiss R
    Lymphokine Cytokine Res; 1994 Oct; 13(5):271-5. PubMed ID: 7858059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.
    Potapnev MP; Istomin YP; Ismail-zade RS; Zhavrid EA
    Eksp Onkol; 2004 Mar; 26(1):67-70. PubMed ID: 15112583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models.
    Kraybill WG; Olenki T; Evans SS; Ostberg JR; O'Leary KA; Gibbs JF; Repasky EA
    Int J Hyperthermia; 2002; 18(3):253-66. PubMed ID: 12028640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fever-like whole-body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity, and uropod formation.
    Wang XY; Ostberg JR; Repasky EA
    J Immunol; 1999 Mar; 162(6):3378-87. PubMed ID: 10092792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.